FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Apotex Drospirenone and Ethinyl Estradiol Tablets Recall

Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0

Apotex Inc. · North York, N/A

Risk level
Class II
Reported by FDA
Mar 13, 2019
Recall ID
D-0992-2019
Check your lot numberHow we source this data

Summary

Apotex recalled Drospirenone and Ethinyl Estradiol Tablets starting Mar 1, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0992-2019 on Mar 13, 2019. Reason: Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement. Status: Completed.

Why it was recalled

Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement.

Product description

Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.03 mg, 28 Tablets Blister, 1 Unit (NDC 60505-4183-1) packaged as 84 Tablets Blister, 3x1 Unit per carton (NDC 60505-4183-3), Rx Only, Manufactured for: Apotex Corp., Weston, FL 33326; Manufactured by: Oman Pharmaceutical Products Co. L.L.C., P.O. Box 1885, Postal Code 111, Seeb.

Lot numbers, UPCs & expiration codes

Lots: 7DY008A, 7DY009A, 7DY010A, 7DY011A, Exp. 08/2020

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0992-2019
Classification
Class II
Status
Completed
Recall initiated
Mar 1, 2019
FDA report date
Mar 13, 2019
Quantity
82,705 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Inc.

Original FDA data

Every field from FDA enforcement report D-0992-2019, exactly as published.

Show all FDA fields
City
North York
Status
Completed
Country
Canada
Event ID
82288
Address
150 Signet Drive
Code information
Lots: 7DY008A, 7DY009A, 7DY010A, 7DY011A, Exp. 08/2020
Report date
Mar 13, 2019
Product type
Drugs
Recall number
D-0992-2019
Classification
Class II
Recalling firm
Apotex Inc.
Product quantity
82,705 cartons
Reason for recall
Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.03 mg, 28 Tablets Blister, 1 Unit (NDC 60505-4183-1) packaged as 84 Tablets Blister, 3x1 Unit per carton (NDC 60505-4183-3), Rx Only, Manufactured for: Apotex Corp., Weston, FL 33326; Manufactured by: Oman Pharmaceutical Products Co. L.L.C., P.O. Box 1885, Postal Code 111, Seeb.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Mar 1, 2019
Initial firm notification
Press Release
Center classification date
Mar 11, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0992-2019, published Mar 13, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls